Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/14/2005CN1668645A Methods and copositions for the treatment of ischemic reperfusion
09/14/2005CN1668631A Fractionation of phytosterol esters in oil
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668627A Process for producing glycoside
09/14/2005CN1668623A Pseudopolymorphic forms of a HIV protease inhibitor
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
09/14/2005CN1668620A 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668617A Process for the preparation of imidazo(1, 2-A)pyridine-3-acetamides
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668610A Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668606A Oxazole derivatives and their use as insulin sensitizers
09/14/2005CN1668605A Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
09/14/2005CN1668604A Novel anthracene derivatives and the use thereof as a medicament
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
09/14/2005CN1668598A Use of chemotherapeutic agents
09/14/2005CN1668594A New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668586A Method for preparing 13 5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668583A Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents
09/14/2005CN1668580A Aminoacetonitriles derivant for controlling parasite
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/14/2005CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress
09/14/2005CN1668565A Substituted 1, 3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
09/14/2005CN1668561A Remedy
09/14/2005CN1668336A Drug transport and delivery system
09/14/2005CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668323A Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
09/14/2005CN1668321A Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
09/14/2005CN1668319A Antiflatulent composition, antiflatulent healthy drink and large intestine inside wash fluid
09/14/2005CN1668318A Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
09/14/2005CN1668313A Medicinal composition for drug-induced neuropathy
09/14/2005CN1668312A Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions
09/14/2005CN1668311A Method and composition for treating diabetes
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668309A Trimegestone and estrogens for treating post menopausal disorders
09/14/2005CN1668307A New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2, 3-d]pyrimidine
09/14/2005CN1668306A 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-((pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-RET kinase associated diseases
09/14/2005CN1668305A Microbicidal pyrimidine or triazine for preventing sexual HIV transmission
09/14/2005CN1668304A Crystalline 2, 5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
09/14/2005CN1668303A Selective estrogen receptor modulators containing a phenylsulfonyl group
09/14/2005CN1668301A Process for producing coated preparation
09/14/2005CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668298A Antitumor compound and therapeutic uses thereof
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668294A Use of nefopam for the treatment of nausea or emesis
09/14/2005CN1668293A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
09/14/2005CN1668292A Soluble stable pharmaceutical composition for the administration of HIV protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of HIV
09/14/2005CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production
09/14/2005CN1668290A Modified amino acid for the inhibition of platelet aggregation
09/14/2005CN1668289A Modafinil pharmaceutical compositions
09/14/2005CN1668288A Compounds with antiparasitic activity and medicines containing same
09/14/2005CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
09/14/2005CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea
09/14/2005CN1668285A Lasofoxifene tablet and its coating
09/14/2005CN1668284A Sustained release oral dosage forms of gabapentin
09/14/2005CN1668283A Pharmaceutical compositions with improved dissolution
09/14/2005CN1668282A Directly compressible formulations of azithromycin
09/14/2005CN1668281A Nanoparticulate fibrate formulations
09/14/2005CN1668278A Bioerodible film for ophthalmic drug delivery
09/14/2005CN1668277A Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
09/14/2005CN1668213A Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
09/14/2005CN1668212A Compositions comprising lactoferrin
09/14/2005CN1667416A Diagnostics and therapeutics for glaucoma
09/14/2005CN1666998A Fucoidan and its use
09/14/2005CN1666994A Zinc bismuth glycyrrhetate (compound) and preparation method thereof
09/14/2005CN1666992A Medical use of catalpol and its homologs
09/14/2005CN1666991A Processes for preparing clarithromycin polymorphs and novel polymorph IV
09/14/2005CN1666986A Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666984A Process for extracting epigoitrin from isatis root and use thereof
09/14/2005CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof
09/14/2005CN1666751A Prescription for treating type 2 diabetes and its preparing method
09/14/2005CN1666749A Application of lucid ganoderma polysaccharide and spine date seed total flavone in preparing process of hypnotic and health caring product
09/14/2005CN1666748A Oral formulation of adetphos
09/14/2005CN1666747A Fructose injection of anti-tumor drug
09/14/2005CN1666746A Laevulose injection of antiviral drug
09/14/2005CN1666745A Drug composition for treating osteoporosis
09/14/2005CN1666744A Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof
09/14/2005CN1666743A 复方头孢克洛分散片 Compound Cefaclor tablet
09/14/2005CN1666742A Combination therapy to treat hepatitis b virus
09/14/2005CN1666741A Stable naloxone freeze dried powder injection and preparation technology thereof
09/14/2005CN1666740A Application of tetrandrine and Fangchinoline in preparation of medicine for improving sleep and health products
09/14/2005CN1666739A Application of Silibinin or its salts in preparation of medicine for treating coronary heart disease or strengthening the effect of coronary heart disease treatment